CN101094666B - 改善眼睛的图像质量 - Google Patents

改善眼睛的图像质量 Download PDF

Info

Publication number
CN101094666B
CN101094666B CN2005800202695A CN200580020269A CN101094666B CN 101094666 B CN101094666 B CN 101094666B CN 2005800202695 A CN2005800202695 A CN 2005800202695A CN 200580020269 A CN200580020269 A CN 200580020269A CN 101094666 B CN101094666 B CN 101094666B
Authority
CN
China
Prior art keywords
zeaxanthin
lutein
eye
composition
image quality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800202695A
Other languages
English (en)
Chinese (zh)
Other versions
CN101094666A (zh
Inventor
约翰·巴布尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN101094666A publication Critical patent/CN101094666A/zh
Application granted granted Critical
Publication of CN101094666B publication Critical patent/CN101094666B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Eye Examination Apparatus (AREA)
CN2005800202695A 2004-06-29 2005-06-08 改善眼睛的图像质量 Expired - Fee Related CN101094666B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04015189.6 2004-06-29
EP04015189 2004-06-29
PCT/EP2005/006168 WO2006002735A1 (en) 2004-06-29 2005-06-08 Improvement of image quality in the eye

Publications (2)

Publication Number Publication Date
CN101094666A CN101094666A (zh) 2007-12-26
CN101094666B true CN101094666B (zh) 2010-09-29

Family

ID=35782481

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800202695A Expired - Fee Related CN101094666B (zh) 2004-06-29 2005-06-08 改善眼睛的图像质量

Country Status (9)

Country Link
US (2) US20080045605A1 (cg-RX-API-DMAC10.html)
EP (1) EP1761254B1 (cg-RX-API-DMAC10.html)
JP (1) JP5074184B2 (cg-RX-API-DMAC10.html)
KR (1) KR20070027649A (cg-RX-API-DMAC10.html)
CN (1) CN101094666B (cg-RX-API-DMAC10.html)
AT (1) ATE441406T1 (cg-RX-API-DMAC10.html)
DE (1) DE602005016405D1 (cg-RX-API-DMAC10.html)
ES (1) ES2331083T3 (cg-RX-API-DMAC10.html)
WO (1) WO2006002735A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084687A1 (en) * 2005-02-11 2006-08-17 Dsm Ip Assets B.V. Use of zeaxanthin for the treatment of diseases of the peripheral retina
AT503329A1 (de) 2006-03-02 2007-09-15 Omnica Gmbh Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218436B1 (en) * 1993-06-28 2001-04-17 The Howard Foundation Pharmaceutically active carotenoids
US5382714A (en) * 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5827652A (en) * 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
WO1997048388A1 (en) * 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US6075058A (en) * 1998-12-12 2000-06-13 Tufts University Compositions for increased bioavailability of carotenoids
US6712466B2 (en) * 2001-10-25 2004-03-30 Ophthonix, Inc. Eyeglass manufacturing method using variable index layer
WO2003063848A1 (en) * 2002-01-30 2003-08-07 Dsm Ip Assets B.V. Lutein/zeaxanthin for glare protection
CN1481804A (zh) * 2002-12-17 2004-03-17 无锡杰西医药科技有限公司 防治白内障、黄斑变性等眼病的配方及其使用方法

Also Published As

Publication number Publication date
WO2006002735A1 (en) 2006-01-12
JP5074184B2 (ja) 2012-11-14
KR20070027649A (ko) 2007-03-09
EP1761254A1 (en) 2007-03-14
EP1761254B1 (en) 2009-09-02
ES2331083T3 (es) 2009-12-21
ATE441406T1 (de) 2009-09-15
DE602005016405D1 (de) 2009-10-15
JP2008505137A (ja) 2008-02-21
CN101094666A (zh) 2007-12-26
US20110172313A1 (en) 2011-07-14
US20080045605A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
ES2955713T3 (es) Agente de mejora de la función visual, y método para mejorar la función visual
CA2373825C (en) Anthocyanin-containing compositions for foods and drinks and process for producing the same
EP2138055B1 (en) Formula food to be beneficial for visuognosis persistence and use thereof
JP2014506254A (ja) β−ヒドロキシ−β−メチルブチレートを用いる廃用期間後の筋肉回復を促進させるための方法
US20230321023A1 (en) Application of regulation of eye sclera lipid metabolism to inhibit myopia
MX2012009471A (es) Composicion que comprende como ingrediente activo l-carnitina en combinacion con hidroxiquinurenina-o-beta-dl-glucosido, para la prevencion y/o tratamiento de patologias del ojo debido a radiacion ultravioleta.
CN116211939A (zh) 一种修复视神经增强视力的组合物及应用
CN108041609B (zh) 一种具有缓解视疲劳、预防近视的食品组合物及其制备方法
WO2021107106A1 (ja) 経口組成物
CN108078972A (zh) γ-氨基丁酸在制备缓解视疲劳的食品、保健品或药品中的用途
JP7176813B2 (ja) 疲労改善用組成物
CN108324705A (zh) 含茶氨酸、γ-氨基丁酸和花青素的缓解视疲劳的组合物
US20110172313A1 (en) Image quality in the eye
ES2993253T3 (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
CN109222086A (zh) 一种具有缓解视疲劳功效的组合物及其应用和保健食品
JP2022028067A (ja) 網膜保護組成物
WO2022107735A1 (ja) 水晶体硬度調節剤
TWI924107B (zh) 飛蚊症改善劑及飛蚊症的改善方法
US12076358B2 (en) Composition of desmodium and trivalent chromium, and ocular use
JP6838752B2 (ja) 血流改善組成物
CN101115476A (zh) 玉米黄质用于治疗周边视网膜疾病的用途
CN109007813A (zh) 一种具有缓解视疲劳功能的口服液的制作方法
Parker Digital Eye Strain (DES) Supplements: Evidence-Based Guide 2025
HK40091635A (en) Application of regulation of eye sclera lipid metabolism to inhibit myopia
CN115887521A (zh) 一种缓解视觉疲劳的组合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100929

Termination date: 20140608

EXPY Termination of patent right or utility model